Comis Rl
-
- Lung Cancer Research Studies 5
- Peptidase Inhibition and Analysis 2
-
- Cancer therapeutics and mechanisms 4
-
- Neuroendocrine Tumor Research Advances 4
-
- Synthesis of β-Lactam Compounds 2
- Synthesis and Catalytic Reactions 2
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 1
-
- Antifungal resistance and susceptibility 1
- Co-authors
- M PfefferAnthony J. ScalzoRobert GilbertP J O'DwyerBaker LhDeborah KilpatrickCapizzi RlDan Anbar
- Cited by
- OncologyDermatologyMolecular Biology
- Journals
- European Journal of Cancer (1 paper)PubMed (10 papers)
- Partner nations
- United States
In The Last Decade
Comis Rl
11 papers receiving 320 citations
Peers
Comparison fields: 5 of 59
- Oncology 190
- Dermatology 22
- Molecular Biology 151
- Hematology 22
- Pathology and Forensic Medicine 33
Countries citing papers authored by Comis Rl
This map shows the geographic impact of Comis Rl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Comis Rl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Comis Rl more than expected).
Fields of papers citing papers by Comis Rl
This network shows the impact of papers produced by Comis Rl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Comis Rl. The network helps show where Comis Rl may publish in the future.
Co-authorship network
The 12 scholars most cited alongside Comis Rl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Small-cell lung cancer: a perspective on the past and a preview of the future. | 1998 | 21 |
| 2 | 1993 | 1 | |
| 3 | Schedule as a determinant of cytotoxic drug activity. | 1989 | 4 |
| 4 | Oral etoposide in small-cell lung cancer. | 1986 | 4 |
| 5 | Bioavailability and pharmacokinetics of etoposide (VP-16). | 1985 | 78 |
| 6 | Cancer and leukemia group B phase II non-small cell lung carcinoma trial: aziridinylbenzoquinone (AZQ). | 1983 | 2 |
| 7 | Small cell anaplastic carcinoma of the lung. The Cancer and Leukemia Group B Experience. | 1982 | 6 |
| 8 | Phase I trial of chlorozotocin: attempted amelioration of myelotoxicity by glucose administration. | 1981 | 3 |
| 9 | American experience with carminomycin. | 1979 | 10 |
| 10 | Role of single-breath carbon monoxide-diffusing capacity in monitoring the pulmonary effects of bleomycin in germ cell tumor patients. | 1979 | 79 |
| 11 | DTIC (NSC-45388) in malignant melanoma: a perspective. | 1976 | 129 |
About Comis Rl
Comis Rl is a scholar working on Oncology, Epidemiology, Organic Chemistry, Molecular Biology and Pathology and Forensic Medicine, having authored 11 papers that have together received 337 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (5 papers), Cancer therapeutics and mechanisms (4 papers), Neuroendocrine Tumor Research Advances (4 papers), Peptidase Inhibition and Analysis (2 papers), Synthesis of β-Lactam Compounds (2 papers), Synthesis and Catalytic Reactions (2 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 paper) and Antifungal resistance and susceptibility (1 paper). The work is most often cited by research in Oncology (190 citations), Dermatology (22 citations), Molecular Biology (151 citations), Hematology (22 citations) and Pathology and Forensic Medicine (33 citations). Comis Rl has collaborated with scholars based in United States. Frequent co-authors include M Pfeffer, Anthony J. Scalzo, Robert Gilbert, P J O'Dwyer, Baker Lh, Deborah Kilpatrick, Capizzi Rl, Dan Anbar, T C Hamilton and J. Matthew Brennan. Their work appears in journals such as European Journal of Cancer and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.